Liu Jiaqian J - OmicsDI

Show results for

Proteomics (3)
Metabolomics (1)

Organisms

Mus musculus (3)
Homo sapiens (1)

Repository

iProX (3)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (1)
2022 (1)
2021 (1)

CHEBI ID

CHEBI:10333 (1)
CHEBI:1296 (1)
CHEBI:1301 (1)
CHEBI:132620 (1)
CHEBI:132823 (1)
CHEBI:135283 (1)
CHEBI:135293 (1)
CHEBI:137053 (1)
CHEBI:137061 (1)
CHEBI:146130 (1)
CHEBI:146131 (1)
CHEBI:15577 (1)
CHEBI:15578 (1)
CHEBI:156005 (1)
CHEBI:156155 (1)
CHEBI:157749 (1)
CHEBI:157753 (1)
CHEBI:16113 (1)
CHEBI:16229 (1)
CHEBI:16455 (1)
CHEBI:16521 (1)
CHEBI:16581 (1)
CHEBI:166769 (1)
CHEBI:166789 (1)
CHEBI:166797 (1)
CHEBI:166800 (1)
CHEBI:166803 (1)
CHEBI:166807 (1)
CHEBI:166808 (1)
CHEBI:166810 (1)

Metabolite Name

(20,23-cyclo)-cholest-5-en-3beta-ol (1)
(20R)-3beta-hydroxy-5alpha-cholesta-8,24-diene-4-carbaldehyde (1)
(22,23-dinor)-24-vinyl-cholest-5-en-3beta,24-diol (1)
(22R,23R)-methylene-cholest-5-en-3beta-ol (1)
(24R)-cholest-5-en-3beta,24-diol (1)
(24S)-26-nor-5alpha-cholest-22E-en-3beta-ol (1)
(25R)-24R,26R-dimethyl-26,27-cyclo-5alpha-cholestan-3beta-ol (1)
(25R)-24R,26R-dimethyl-26,27-cyclo-cholest-5-en-3beta-ol (1)
(25S)-24R,26-dimethylcholest-5-en-3beta-ol (1)
(25S)-24S,26-cyclocholest-5-en-3beta-ol (1)
(25S)-5alpha-spirostan-3beta-ol (1)
(25S)-5beta-spirostan-3beta-ol (1)
(3S,6R)-9,10-seco-5(10),6,7-cholestatrien-3-ol (1)
(3S,6R,9R)-9(10-6)abeo-5(10),7-cholestadien-3-ol (1)
(3S,6S)-9,10-seco-5(10),6,7-cholestatrien-3-ol (1)
(3beta,22R)-stigmasta-4,6-diene-3,22-diol (1)
(5E,7E)-(3S)-6-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5E,7E)-(3S,22R)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5E,7E,10E)-(3S)-19-methyl-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5E,7E,22E)-(3S,10S)-9,10-seco-5,7,22-ergostatrien-3-ol (1)
(5Z,7E)-(1S,3R)-1,3,21-trihydroxy-9,10-seco-5,7,10(19)-pregnatrien-20-one (1)
(5Z,7E)-(1S,3R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol (1)
(5Z,7E)-(1S,3R)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol (1)
(5Z,7E)-(3S)-22-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5Z,7E)-(3S)-23,23-difluoro-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol (1)
(5Z,7E)-(3S)-23,24-dinor-9,10-seco-5,7,10(19)-cholatrien-3,22-diol (1)
(5Z,7E)-(3S)-25-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5Z,7E)-(3S,22R)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5Z,7E)-(3S,22S)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5Z,7E,10E)-(3S)-19-methyl-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain

Aberrant sterol lipid metabolism is associated with physiological dysfunctions in the aging brain and aging-dependent disorders such as neurodegenerative diseases. There is an unmet demand to comprehensively profile sterol lipids spatially and temporally in different brain regions during aging. Here...

2021-05-24 | MTBLS2457 | MetaboLights

Quantitative acetylomics reveals dynamics of protein lysine acetylation in mouse livers during aging and upon the treatment of nicotinamide mononucleotide

Acetylome of livers of aging mouse and NMN treatment mouse

ORGANISM(S): Mus Musculus

2022-02-23 | PXD031851 |

Lysine-targeting, covalent inhibitors of bromodomain BD1 of BET proteins in live cells and animals

We report herein a set of activity-based probes (ABPs; P3-P7) based on various lysine-reactive covalent warheads capable of global profiling of ligandable lysine within BRDs in live cells and animals. Chemoproteomic experiments with P7 by utilizing 2-ethynylbenzaldehyde (EBA) identified 18 endogenou...

ORGANISM(S): Homo Sapiens Mus Musculus

PXD058513 |

Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12

This project aims to characterize the endothelial cell proteome labeled by tumor-derived secreted Sema3C in metastatic lymph nodes using an in vivo TurboID-based proximity labeling strategy. EO771 breast cancer cells overexpressing either a secreted p65-Sema3C–TurboID fusion protein or TurboID alone...